|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Chlamydia and Chlamydophila Antibody Panel 2 (IgM)
Test Code37126
CPT Codes
86632 (x3)
Includes
Chlamydia trachomatis (IgM)
Chlamydophila pneumoniae (IgM)
Chlamydophila psittaci (IgM)
Chlamydophila pneumoniae (IgM)
Chlamydophila psittaci (IgM)
Preferred Specimen
1 mL serum
Minimum Volume
0.1 mL
Instructions
Serum: Collect in a serum separator tube or red-top tube (no gel). The tube should be centrifuged after clotting. Spun serum separator tubes may be submitted at room temperature or refrigerated unopened without transfer to a plastic screw-cap vial.
Red-top tube (no gel) serum should be transferred to a plastic screw-cap vial and submitted for testing.
Red-top tube (no gel) serum should be transferred to a plastic screw-cap vial and submitted for testing.
Transport Container
Plastic screw-cap vial
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Samples submitted in original red-top tube (no gel) • Gross hemolysis • Grossly lipemic • Grossly icteric
Methodology
Immunofluorescence Assay (IFA)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Mon-Sat; Report available: 1-3 days
Reference Range
C. trachomatis (IgM) | <1:10 |
C. pneumoniae (IgM) | <1:10 |
C. psittaci (IgM) | <1:10 |
Clinical Significance
Chlamydia/Chlamydophila species include C. pneumoniae, C. psittaci, and C. trachomatis. Each may cause pneumonia and other overlapping medical conditions.